Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Padilla

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Bioorganic & Medicinal Chemistry Letters|November 19, 2008
Discovery of a potent, selective and orally bioavailable 3,9-diazaspiro[5.5]undeca-2-one CCR5 antagonistHanbiao Yang, Xiao-Fa Lin, Fernando Padilla, et al.
British Journal of Pharmacology|March 22, 2005
Antagonism of ATP responses at P2X receptor subtypes by the pH indicator dye, Phenol redBrian F King, Min Liu, Andrea Townsend-Nicholson, et al.
Journal of Neuroscience Methods|March 18, 2022
Reversible focal intracranial hypertension swine model with continuous multimodal neuromonitoringNicolas Marcelo Ciarrocchi, Fernando Pose, Pablo Saez, et al.
Bioorganic & Medicinal Chemistry Letters|May 12, 2010
Synthesis, SAR and evaluation of [1,4']-bipiperidinyl-4-yl-imidazolidin-2-one derivatives as novel CCR5 antagonistsDavid M Rotstein, Stephen D Gabriel, Nicole Manser, et al.
Idcases|December 5, 2022
Monkeypox and its broad clinical spectrum in immunocompromised patients: Two case reportsCarlos Adrián Pérez Martínez, Gustavo Antolin Silva Flores, Fernando Padilla Santamaría, et al.
Research in Veterinary Science|April 20, 2007
Diagnosis of canine brucellosis by ELISA using an antigen obtained from wild Brucella canisStella Maria Barrouin-Melo, Fernando Padilla Poester, Marcos Borges Ribeiro, et al.
Journal of Medicinal Chemistry|November 16, 2012
Rational design of highly selective spleen tyrosine kinase inhibitorsMatthew C Lucas, David M Goldstein, Johannes C Hermann, et al.
World Neurosurgery|December 16, 2024
Conventional Radiotherapy Timing and Wound Complication Avoidance After Surgery for Metastatic Spine Disease. A LatAm Modified Delphi StudyFederico Landriel, Kevin White, Fernando Padilla Lichtenberger, et al.
Journal of Medicinal Chemistry|February 14, 2014
Using ovality to predict nonmutagenic, orally efficacious pyridazine amides as cell specific spleen tyrosine kinase inhibitorsMatthew C Lucas, Niala Bhagirath, Eric Chiao, et al.
Journal of Medicinal Chemistry|October 14, 2015
Novel Series of Dihydropyridinone P2X7 Receptor AntagonistsFrancisco Lopez-Tapia, Keith A M Walker, Christine Brotherton-Pleiss, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Bioorganic & Medicinal Chemistry Letters|November 19, 2008
Discovery of a potent, selective and orally bioavailable 3,9-diazaspiro[5.5]undeca-2-one CCR5 antagonistHanbiao Yang, Xiao-Fa Lin, Fernando Padilla, et al.
British Journal of Pharmacology|March 22, 2005
Antagonism of ATP responses at P2X receptor subtypes by the pH indicator dye, Phenol redBrian F King, Min Liu, Andrea Townsend-Nicholson, et al.
Journal of Neuroscience Methods|March 18, 2022
Reversible focal intracranial hypertension swine model with continuous multimodal neuromonitoringNicolas Marcelo Ciarrocchi, Fernando Pose, Pablo Saez, et al.
Bioorganic & Medicinal Chemistry Letters|May 12, 2010
Synthesis, SAR and evaluation of [1,4']-bipiperidinyl-4-yl-imidazolidin-2-one derivatives as novel CCR5 antagonistsDavid M Rotstein, Stephen D Gabriel, Nicole Manser, et al.
Idcases|December 5, 2022
Monkeypox and its broad clinical spectrum in immunocompromised patients: Two case reportsCarlos Adrián Pérez Martínez, Gustavo Antolin Silva Flores, Fernando Padilla Santamaría, et al.
Research in Veterinary Science|April 20, 2007
Diagnosis of canine brucellosis by ELISA using an antigen obtained from wild Brucella canisStella Maria Barrouin-Melo, Fernando Padilla Poester, Marcos Borges Ribeiro, et al.
Journal of Medicinal Chemistry|November 16, 2012
Rational design of highly selective spleen tyrosine kinase inhibitorsMatthew C Lucas, David M Goldstein, Johannes C Hermann, et al.
World Neurosurgery|December 16, 2024
Conventional Radiotherapy Timing and Wound Complication Avoidance After Surgery for Metastatic Spine Disease. A LatAm Modified Delphi StudyFederico Landriel, Kevin White, Fernando Padilla Lichtenberger, et al.
Journal of Medicinal Chemistry|February 14, 2014
Using ovality to predict nonmutagenic, orally efficacious pyridazine amides as cell specific spleen tyrosine kinase inhibitorsMatthew C Lucas, Niala Bhagirath, Eric Chiao, et al.
Journal of Medicinal Chemistry|October 14, 2015
Novel Series of Dihydropyridinone P2X7 Receptor AntagonistsFrancisco Lopez-Tapia, Keith A M Walker, Christine Brotherton-Pleiss, et al.
Pageof 5